Epic Sciences Names Board Member

San Diego-based Epic Sciences has named Gregory C. Critchfield to its board of directors, the company said this morning. Critchfield is the chairman, president and CEO of Sera Prognostics, and also has was previously President of Myriad Genetics. Epic Sciences is developing diagnostics products aimed at personalized treatment and management of cancer. The company's backers include RusnanoMedInvest (RMI), Arcus Ventures, Domain Associates, Roche Venture Fund, and Pfizer, among others.